Market Closed -
Bombay S.E.
06:00:50 2024-04-26 am EDT
|
5-day change
|
1st Jan Change
|
2,751
INR
|
-0.62%
|
|
+1.87%
|
-2.07%
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
27,416
|
38,835
|
25,515
|
39,117
|
77,942
|
80,577
|
Enterprise Value (EV)
1 |
56,748
|
73,377
|
62,265
|
63,963
|
103,136
|
109,709
|
P/E ratio
|
11.2
x
|
11.5
x
|
4.81
x
|
6.46
x
|
8.14
x
|
6.46
x
|
Yield
|
0.35%
|
0.25%
|
0.76%
|
1.78%
|
1.34%
|
1.32%
|
Capitalization / Revenue
|
0.49
x
|
0.5
x
|
0.35
x
|
0.46
x
|
0.63
x
|
0.54
x
|
EV / Revenue
|
1.01
x
|
0.95
x
|
0.86
x
|
0.76
x
|
0.83
x
|
0.74
x
|
EV / EBITDA
|
6.04
x
|
5.28
x
|
4.27
x
|
3.02
x
|
3.33
x
|
3.04
x
|
EV / FCF
|
-6.13
x
|
-13.4
x
|
-13.9
x
|
-30.8
x
|
-26.1
x
|
-19.7
x
|
FCF Yield
|
-16.3%
|
-7.47%
|
-7.17%
|
-3.25%
|
-3.84%
|
-5.08%
|
Price to Book
|
1.41
x
|
1.71
x
|
0.91
x
|
1.04
x
|
1.61
x
|
1.41
x
|
Nbr of stocks (in thousands)
|
32,263
|
32,263
|
32,263
|
32,263
|
32,263
|
32,091
|
Reference price
2 |
849.8
|
1,204
|
790.8
|
1,212
|
2,416
|
2,511
|
Announcement Date
|
9/28/18
|
9/5/19
|
10/7/20
|
9/3/21
|
7/19/22
|
7/17/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
55,953
|
77,019
|
72,426
|
84,282
|
124,660
|
148,848
|
EBITDA
1 |
9,395
|
13,900
|
14,565
|
21,208
|
30,938
|
36,063
|
EBIT
1 |
6,120
|
10,119
|
10,704
|
16,871
|
26,018
|
30,661
|
Operating Margin
|
10.94%
|
13.14%
|
14.78%
|
20.02%
|
20.87%
|
20.6%
|
Earnings before Tax (EBT)
1 |
5,786
|
8,172
|
9,180
|
16,143
|
25,931
|
29,996
|
Net income
1 |
2,437
|
3,386
|
5,302
|
6,060
|
9,574
|
12,537
|
Net margin
|
4.36%
|
4.4%
|
7.32%
|
7.19%
|
7.68%
|
8.42%
|
EPS
2 |
75.55
|
104.6
|
164.3
|
187.8
|
296.7
|
388.8
|
Free Cash Flow
1 |
-9,261
|
-5,479
|
-4,465
|
-2,076
|
-3,957
|
-5,572
|
FCF margin
|
-16.55%
|
-7.11%
|
-6.16%
|
-2.46%
|
-3.17%
|
-3.74%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
3.000
|
3.000
|
6.000
|
21.60
|
32.40
|
33.20
|
Announcement Date
|
9/28/18
|
9/5/19
|
10/7/20
|
9/3/21
|
7/19/22
|
7/17/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
29,332
|
34,543
|
36,750
|
24,847
|
25,194
|
29,133
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
3.122
x
|
2.485
x
|
2.523
x
|
1.172
x
|
0.8143
x
|
0.8078
x
|
Free Cash Flow
1 |
-9,261
|
-5,479
|
-4,465
|
-2,076
|
-3,957
|
-5,572
|
ROE (net income / shareholders' equity)
|
13.5%
|
16.6%
|
19.2%
|
19.5%
|
23.5%
|
23.5%
|
ROA (Net income/ Total Assets)
|
4.84%
|
6.67%
|
6.3%
|
8.65%
|
11%
|
10.8%
|
Assets
1 |
50,377
|
50,744
|
84,106
|
70,047
|
86,815
|
116,050
|
Book Value Per Share
2 |
604.0
|
704.0
|
867.0
|
1,164
|
1,499
|
1,781
|
Cash Flow per Share
2 |
31.00
|
62.60
|
36.60
|
66.60
|
163.0
|
192.0
|
Capex
1 |
14,010
|
11,124
|
15,314
|
12,147
|
18,339
|
28,437
|
Capex / Sales
|
25.04%
|
14.44%
|
21.14%
|
14.41%
|
14.71%
|
19.1%
|
Announcement Date
|
9/28/18
|
9/5/19
|
10/7/20
|
9/3/21
|
7/19/22
|
7/17/23
|
|
1st Jan change
|
Capi.
|
---|
| -2.07% | 1.06B | | +5.14% | 103B | | -5.63% | 63.04B | | +39.52% | 39.06B | | +12.91% | 37.58B | | +7.41% | 33.24B | | +6.85% | 19.22B | | +12.86% | 16.83B | | +7.73% | 15.03B | | +16.93% | 14.96B |
Other Commodity Chemicals
|